跳至主要内容
临床试验/EUCTR2016-001042-25-Outside-EU/EEA
EUCTR2016-001042-25-Outside-EU/EEA进行中(未招募)1 期

A Study to Investigate the Impact of Pharmacogenetics on CellCept Use, in Patients Participating in a Study in Renal Transplantation

F. Hoffmann-La Roche AG0 个研究点目标入组 720 人开始时间: 2016年10月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
720

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - male or female patients 13-75 years of age
  • - single organ recipient (kidney only) from living (related or unrelated) or cadaveric heart-beating donors
  • - patient receiving first or second kidney transplant
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 20
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 650
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • - immunosuppressive therapy (except corticosteroid treatment) within previous 28 days for a first transplant and 3 months for a second transplant
  • - history of malignancy in last 5 years (except successfully treated localized non-melanoma skin cancer)

研究者

相似试验

Pharmacogenetic Study of CellCept (Mycophenolate... | 临床试验